Anna M. Szpurka
- Immunology top 10%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 2
- Lung Cancer Research Studies 2
- Peptidase Inhibition and Analysis 2
-
- Lung Cancer Treatments and Mutations 4
- Advanced Breast Cancer Therapies 3
- Sarcoma Diagnosis and Treatment 2
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Leena GandhiVioleta Régnier GalvãoToshihiko DoiChing Ching LeowBoris CalderónDanni YuAmita PatnaikMaria J. de Miguel
- Partner nations
- United StatesFranceBelgium
In The Last Decade
Anna M. Szpurka
19 papers receiving 424 citations
Peers
Comparison fields: 5 of 41
- Immunology 221
- Oncology 265
- Biological Psychiatry 14
- Pulmonary and Respiratory Medicine 107
- Cancer Research 49
Countries citing papers authored by Anna M. Szpurka
This map shows the geographic impact of Anna M. Szpurka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Szpurka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Szpurka more than expected).
Fields of papers citing papers by Anna M. Szpurka
This network shows the impact of papers produced by Anna M. Szpurka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Szpurka. The network helps show where Anna M. Szpurka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna M. Szpurka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 31 | |
| 8 | 2021 | 116 | |
| 9 | 2021 | 84 | |
| 10 | 2021 | 35 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 29 | |
| 13 | 2020 | 31 | |
| 14 | 2020 | 9 | |
| 15 | 2020 | 37 | |
| 16 | 2020 | 9 | |
| 17 | 2019 | 9 | |
| 18 | 2019 | 2 | |
| 19 | 2019 | 2 | |
| 20 | 2018 | 2 |
About Anna M. Szpurka
Anna M. Szpurka is a scholar working on Oncology, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 433 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (4 papers), Advanced Breast Cancer Therapies (3 papers), CAR-T cell therapy research (2 papers), Lung Cancer Research Studies (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Immunology (221 citations), Oncology (265 citations) and Biological Psychiatry (14 citations). Anna M. Szpurka has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Leena Gandhi, Violeta Régnier Galvão, Toshihiko Doi, Ching Ching Leow, Boris Calderón, Danni Yu, Amita Patnaik, Maria J. de Miguel, Yung‐Jue Bang and Sylvie Rottey.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.